{"transactions":[{"id":4624201,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-18T20:43:02.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":85887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":85887,"derivative":{"underlying":"Common Stock","underlying_shares":85887},"source":{"system":"sec-edgar","filing":"0001821353-26-000007","document":"form4a-09182026_080955.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000182135326000007/form4a-09182026_080955.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4624200,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T20:43:02.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":85887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":85887,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":85887},"source":{"system":"sec-edgar","filing":"0001821353-26-000007","document":"form4a-09182026_080955.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000182135326000007/form4a-09182026_080955.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4618673,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-09-15T23:05:52.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":85887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":85887,"derivative":{"underlying":"Common Stock","underlying_shares":85887},"source":{"system":"sec-edgar","filing":"0001821353-26-000005","document":"form4-09152026_110942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821353/000182135326000005/form4-09152026_110942.xml","form_type":"4"}},{"id":4618672,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-15T23:05:52.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":85887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":85887,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":85887},"source":{"system":"sec-edgar","filing":"0001821353-26-000005","document":"form4-09152026_110942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821353/000182135326000005/form4-09152026_110942.xml","form_type":"4"}},{"id":816115,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-03T22:22:38.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":282340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2026."}],"balance_after":282340,"derivative":{"exercise_price":3.54,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":282340},"source":{"system":"sec-edgar","filing":"0001821353-26-000003","document":"form4-04032026_100433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000182135326000003/form4-04032026_100433.xml","form_type":"4"}},{"id":1227752,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T23:11:15.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":687979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean February 18, 2025."}],"balance_after":687979,"derivative":{"exercise_price":2.305,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":687979},"source":{"system":"sec-edgar","filing":"0001415889-25-006678","document":"form4-03042025_110311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006678/form4-03042025_110311.xml","form_type":"4"}},{"id":1258459,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T16:15:07.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to the vesting date."}],"balance_after":28125,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001415889-25-004595","document":"form4-02192025_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588925004595/form4-02192025_040201.xml","form_type":"4"}},{"id":1258458,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-02-19T16:15:07.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4152,"price":0.6717,"value":2788.8984,"ownership":{"direct":true},"balance_after":5223,"source":{"system":"sec-edgar","filing":"0001415889-25-004595","document":"form4-02192025_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588925004595/form4-02192025_040201.xml","form_type":"4"}},{"id":1258457,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-02-19T16:15:07.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":9375,"source":{"system":"sec-edgar","filing":"0001415889-25-004595","document":"form4-02192025_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588925004595/form4-02192025_040201.xml","form_type":"4"}},{"id":1632434,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-02-20T16:52:31.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs vest on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs do not expire; they either vest or are canceled prior to the vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001415889-24-004392","document":"form4-02202024_090212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588924004392/form4-02202024_090212.xml","form_type":"4"}},{"id":1632433,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-20T16:52:31.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on February 15, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.77,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001415889-24-004392","document":"form4-02202024_090212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588924004392/form4-02202024_090212.xml","form_type":"4"}},{"id":2006300,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T16:26:45.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on February 15, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":130000,"derivative":{"exercise_price":0.98,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-23-002769","document":"form4-02172023_090219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588923002769/form4-02172023_090219.xml","form_type":"4"}},{"id":2057205,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-10T16:27:55.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested as to 25% of the total shares on January 6, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":130000,"derivative":{"exercise_price":0.75,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-23-000728","document":"form4-01102023_090138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000141588923000728/form4-01102023_090138.xml","form_type":"4"}},{"id":2330106,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-16T17:46:43.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on March 14, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date and is subject to acceleration in the event of a change in control of the Issuer."}],"balance_after":230000,"derivative":{"exercise_price":2.65,"expiration_date":"2032-03-13","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001209191-22-019286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783032/000120919122019286/doc4.xml","form_type":"4"}},{"id":2378585,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-24T02:19:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022."}],"balance_after":210000,"derivative":{"exercise_price":3.08,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0000899243-22-007520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000089924322007520/doc4.xml","form_type":"4"}},{"id":2874487,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":53812,"kind":"person","name":"Dornan David","position":1,"cik":"0001821353","reported_name":"Dornan David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T22:04:14.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/48th of the Shares will vest upon the Reporting Person completing each month of continuous service following February 4, 2021."}],"balance_after":110000,"derivative":{"exercise_price":20,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-21-008527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000120919121008527/doc4.xml","form_type":"4"}}]}